Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a liver or kidney fibrocystic disease (a condition where fluid-filled cysts form in the liver or kidneys), confirmed through medical records, imaging scans, a tissue sample, autopsy findings, or genetic testing.
Who may not be able to join:
- People who have Autosomal Dominant Polycystic Kidney Disease (ADPKD), which is a specific inherited form of kidney cyst disease.
- People who have abnormalities in the urinary tract (the system that carries urine from the kidneys out of the body).
- People who have major birth defects affecting other body systems.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lisa Guay-Woodford, MD, Children's Hospital of Philadelphia
Phone: 267-425-5325
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource (Hepato/Renal Fibrocystic Diseases Core Center (UAB HRFDCC))
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.